Personalis Inc. Common Stock vs StoneX Group Inc. Common Stock — how do they compare? Personalis Inc. Common Stock trades at $16.07 (market cap $1.69B), while StoneX Group Inc. Common Stock trades at $59.76 (market cap $7.27B). The key difference: StoneX Group Inc. Common Stock is far larger — about 4.3× Personalis Inc. Common Stock's market cap, and Personalis Inc. Common Stock is trading nearer its 52-week high, StoneX Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Personalis Inc. Common Stock for 0 Days and StoneX Group Inc. Common Stock for 0 Days on average.
| PSNL | SNEX | |
|---|---|---|
Market Cap | $1.69B | $7.27B |
Volume | 3,817,236 | 1,624,795 |
Sector | Health | Financials |
52-Week High | $18.38 | $92.67 |
52-Week Low | $5.04 | $37.20 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.52B | $28.28B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →StoneX Group Inc. is a financial services firm providing trading, clearing, execution, and cross-border payment services to institutional, commercial, and self-directed retail clients across global markets.
Read more on SNEX →